The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double-blind, placebo-controlled trial

Published:2006 Issue:11 Volume:54 Page:3623-3632
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Tseng Chung-E,Buyon Jill P.,Kim Mimi,Belmont H. Michael,Mackay Meggan,Diamond Betty,Marder Galina,Rosenthal Pamela,Haines Kathleen,Ilie Virginia,Abramson Steven B.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference42 articles.

1. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study

2. Outcome of Systemic Lupus Erythematosus a Study of 66 Patients over 7 Years with Special Reference to the Predictive Value of Anti-DNA Antibody Determinations

3. Measurement of increases in anti-double-stranded dna antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus

4. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical application of serologic tests, serum protein abnormalities, and other laboratory tests in systemic lupus erythematosus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Antinuclear antibodies, antibodies to DNA, histones, and nucleosomes;Dubois' Lupus Erythematosus and Related Syndromes;2025

3. KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis. Translated into Russian by E.V. Zakharova;Nephrology and Dialysis;2024-08-13

4. Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohort;Med;2024-07

5. No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study;Rheumatology International;2024-04-26